|Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy|
X Li, MT Lewis, J Huang, C Gutierrez, CK Osborne, MF Wu, ...
Journal of the National Cancer Institute 100 (9), 672-679, 2008
|Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features|
CJ Creighton, X Li, M Landis, JM Dixon, VM Neumeister, A Sjolund, ...
Proceedings of the National Academy of Sciences 106 (33), 13820-13825, 2009
|Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer|
MD Burstein, A Tsimelzon, GM Poage, KR Covington, A Contreras, ...
Clinical Cancer Research, 2014
|Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer|
JC Chang, EC Wooten, A Tsimelzon, SG Hilsenbeck, MC Gutierrez, ...
The Lancet 362 (9381), 362-369, 2003
|Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer|
CK Osborne, V Bardou, TA Hopp, GC Chamness, SG Hilsenbeck, ...
Journal of the National Cancer Institute 95 (5), 353-361, 2003
|Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes|
RM Lavinsky, K Jepsen, T Heinzel, J Torchia, TM Mullen, R Schiff, ...
Proceedings of the National Academy of Sciences 95 (6), 2920-2925, 1998
|BRCAPRO Validation, Sensitivity of Genetic Testing of BRCA1/BRCA2, and Prevalence of Other Breast Cancer Susceptibility Genes|
DA Berry, ES Iversen Jr, DF Gudbjartsson, EH Hiller, JE Garber, ...
Journal of Clinical Oncology 20 (11), 2701-2712, 2002
|Medical complications and outcomes after hip fracture repair|
VA Lawrence, SG Hilsenbeck, H Noveck, RM Poses, JL Carson
Archives of internal medicine 162 (18), 2053-2057, 2002
|p53 is mutated in a subset of advanced-stage prostate cancers|
R Bookstein, D MacGrogan, SG Hilsenbeck, F Sharkey, DC Allred
Cancer research 53 (14), 3369-3373, 1993
|A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models|
X Zhang, S Claerhout, A Prat, LE Dobrolecki, I Petrovic, Q Lai, MD Landis, ...
Cancer research 73 (15), 4885-4897, 2013
|Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.|
ML Rothenberg, JR Eckardt, JG Kuhn, HA Burris 3rd, J Nelson, ...
Journal of Clinical Oncology 14 (4), 1128-1135, 1996
|Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer|
CK Osborne, EB Coronado-Heinsohn, SG Hilsenbeck, BL McCue, ...
JNCI: Journal of the National Cancer Institute 87 (10), 746-750, 1995
|Enhancement of Insulin-Like Growth Factor Signaling in Human Breast Cancer: Estrogen Regulation of Insulin Receptor Substrate-1 Expression in Vitro and in Vivo|
AV Lee, JG Jackson, JL Gooch, SG Hilsenbeck, E Coronado-Heinsohn, ...
Molecular Endocrinology 13 (5), 787-796, 1999
|A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis|
JD Kessler, KT Kahle, T Sun, KL Meerbrey, MR Schlabach, EM Schmitt, ...
Science 335 (6066), 348-353, 2012
|Incidence and hospital stay for cardiac and pulmonary complications after abdominal surgery|
VA Lawrence, SG Hilsenbeck, CD Mulrow, R Dhanda, J Sapp, CP Page
Journal of general internal medicine 10 (12), 671-678, 1995
|Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8|
ZC Hartman, GM Poage, P den Hollander, A Tsimelzon, J Hill, ...
Cancer research 73 (11), 3470-3480, 2013
|Risk of pulmonary complications after elective abdominal surgery|
VA Lawrence, R Dhanda, SG Hilsenbeck, CP Page
Chest 110 (3), 744-750, 1996
|Phase I and pharmacokinetic trial of weekly CPT-11.|
ML Rothenberg, JG Kuhn, HA Burris 3rd, J Nelson, JR Eckardt, ...
Journal of Clinical Oncology 11 (11), 2194-2204, 1993
|Identification of tumor-initiating cells in a p53-null mouse model of breast cancer|
M Zhang, F Behbod, RL Atkinson, MD Landis, F Kittrell, D Edwards, ...
Cancer research 68 (12), 4674-4682, 2008
|Diagnostic yield of clinical tumor and germline whole-exome sequencing for children with solid tumors|
DW Parsons, A Roy, Y Yang, T Wang, S Scollon, K Bergstrom, ...
JAMA oncology 2 (5), 616-624, 2016